Tao Li Selected Research

rho-Associated Kinases

10/2022	Acquired temozolomide resistance in MGMTlow gliomas is associated with regulation of homologous recombination repair by ROCK2.
11/2019	ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1.
10/2017	Involvement of connexin 43 phosphorylation and gap junctional communication between smooth muscle cells in vasopressin-induced ROCK-dependent vasoconstriction after hemorrhagic shock.
11/2016	Beneficial Effect of Intermedin 1-53 in Septic Shock Rats: Contributions of Rho Kinase and BKCA Pathway-Mediated Improvement in Cardiac Function.
3/2016	Non-muscle myosin light chain promotes endothelial progenitor cells senescence and dysfunction in pulmonary hypertensive rats through up-regulation of NADPH oxidase.
5/2015	Beneficial and side effects of arginine vasopressin and terlipressin for septic shock.
2/2015	Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway.
1/2015	Bradykinin induces vascular contraction after hemorrhagic shock in rats.
11/2014	Beneficial effects of platelet-derived growth factor on hemorrhagic shock in rats and the underlying mechanisms.
9/2014	Rho kinase acts as a downstream molecule to participate in protein kinase Cε regulation of vascular reactivity after hemorrhagic shock in rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tao Li Research Topics

Disease

393	Neoplasms (Cancer) 10/2022 - 04/2002
116	Infections 12/2022 - 01/2004
93	Inflammation (Inflammations) 08/2022 - 10/2006
85	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 01/2003
79	Neoplasm Metastasis (Metastasis) 04/2022 - 08/2002
68	Schizophrenia (Dementia Praecox) 01/2022 - 11/2003
65	Hemorrhagic Shock 01/2022 - 11/2005
59	Hypoxia (Hypoxemia) 06/2022 - 01/2006
51	Carcinogenesis 01/2022 - 01/2003
49	Shock 01/2022 - 11/2005
40	Wounds and Injuries (Trauma) 05/2022 - 01/2009
37	Fibrosis (Cirrhosis) 02/2022 - 01/2004
36	Reperfusion Injury 01/2022 - 12/2008
35	COVID-19 12/2022 - 01/2020
35	Carcinoma (Carcinomatosis) 04/2022 - 12/2002
35	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2002
34	Sepsis (Septicemia) 06/2022 - 07/2003
34	Hemorrhage 03/2022 - 02/2004
32	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 03/2006
30	Ischemia 01/2022 - 12/2008
30	Brain Injuries (Brain Injury) 10/2021 - 06/2014
29	Pain (Aches) 04/2022 - 08/2010
29	Stomach Neoplasms (Stomach Cancer) 01/2021 - 10/2004
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2010
26	Necrosis 12/2021 - 04/2006
25	Body Weight (Weight, Body) 07/2022 - 08/2002
25	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 12/2013
24	Glioma (Gliomas) 10/2022 - 03/2011
24	Stroke (Strokes) 01/2022 - 02/2004
23	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2004
22	Lung Neoplasms (Lung Cancer) 02/2022 - 08/2004
21	Myocardial Infarction 02/2023 - 01/2005
21	Infarction (Infarctions) 02/2023 - 01/2005
21	Brain Edema (Cerebral Edema) 01/2022 - 10/2011
21	Liver Neoplasms (Liver Cancer) 01/2022 - 07/2003
20	Hypertension (High Blood Pressure) 02/2022 - 08/2002
17	Esophageal Squamous Cell Carcinoma 03/2022 - 03/2011
17	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 09/2008
17	Malaria 01/2022 - 01/2003
17	Type 2 Diabetes Mellitus (MODY) 11/2021 - 07/2012
16	Obesity 05/2022 - 01/2015
16	Osteoarthritis 04/2022 - 01/2010
16	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 09/2008
16	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021 - 01/2006
16	Chronic Hepatitis B 06/2021 - 01/2012
15	Insulin Resistance 05/2022 - 09/2004
15	Ischemic Stroke 03/2022 - 07/2012
15	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2013
15	Neuroinflammatory Diseases 01/2021 - 11/2009

Drug/Important Bio-Agent (IBA)

158	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2002
81	Pharmaceutical PreparationsIBA 08/2022 - 10/2004
81	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2003
57	Messenger RNA (mRNA)IBA 08/2022 - 07/2003
52	MicroRNAs (MicroRNA)IBA 04/2022 - 04/2012
52	Biological ProductsIBA 02/2022 - 03/2003
48	CytokinesIBA 08/2021 - 07/2003
35	Long Noncoding RNAIBA 01/2022 - 01/2014
35	Therapeutic UsesIBA 01/2022 - 03/2000
31	VaccinesIBA 12/2022 - 07/2004
31	RNA (Ribonucleic Acid)IBA 12/2022 - 03/2013
31	Oxygen (Dioxygen)IBA 06/2022 - 01/2009
29	LipopolysaccharidesIBA 07/2022 - 08/2009
29	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2007
28	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2002
26	Peptides (Polypeptides)IBA 02/2021 - 01/2003
26	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2009
25	EnzymesIBA 10/2022 - 01/2004
25	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2008
25	CalciumIBA 12/2019 - 11/2005
24	LipidsIBA 07/2022 - 05/2003
24	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 09/2004
21	rho-Associated KinasesIBA 10/2022 - 06/2006
21	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2012
21	Neuroprotective AgentsIBA 12/2019 - 01/2013
19	Interleukin-6 (Interleukin 6)IBA 08/2022 - 12/2005
19	AntioxidantsIBA 07/2022 - 05/2013
19	Caspase 3 (Caspase-3)IBA 01/2022 - 01/2011
17	Antiviral Agents (Antivirals)IBA 12/2022 - 04/2006
17	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 05/2011
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2005
16	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2015
16	salicylhydroxamic acid (SHAM)IBA 01/2022 - 04/2011
16	CateninsIBA 01/2022 - 11/2014
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2005
16	LigandsIBA 01/2022 - 12/2004
16	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2018 - 06/2006
15	IronIBA 01/2022 - 04/2009
15	Phosphotransferases (Kinase)IBA 01/2022 - 02/2011
15	Protein Kinase CIBA 10/2017 - 06/2006
14	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 04/2013

Therapy/Procedure

164	Therapeutics 10/2022 - 07/2003
80	Drug Therapy (Chemotherapy) 04/2022 - 03/2000
50	Radiotherapy 03/2022 - 03/2006
26	Resuscitation 01/2022 - 03/2008
25	Ligation 01/2022 - 02/2013
22	Punctures 02/2022 - 10/2010
22	Chemoradiotherapy 01/2022 - 06/2010
20	Aftercare (After-Treatment) 01/2022 - 02/2007
18	Length of Stay 05/2022 - 01/2005
17	Immunotherapy 10/2022 - 01/2004